← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1944)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities. (2022/12/08) ♡
- Application of network composite module analysis and verification to explore the bidirectional immunomodulatory effect of Zukamu granules on Th1 / Th2 cytokines in lung injury. (2022/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe? (2022/12/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy. (2022/12/05) ♡
- Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. (2022/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Organising our thoughts. (2022/12/01) ♡
- Fibrotic Lung Disease Alters Neutrophil Trafficking and Promotes Neutrophil Elastase and Extracellular Trap Release. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progressive pulmonary fibrosis (PPF). (2022/12/01) ♡
- Hiatal hernia and idiopathic pulmonary fibrosis. (2022/12/01) ♡
- Response to "Hiatal hernia and idiopathic pulmonary fibrosis". (2022/12/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations. (2022/12/01) ♡
- Health-related quality of life in a multiracial Asian interstitial lung disease cohort. (2022/12/01) ♡
- The Vasculature in Pulmonary Fibrosis. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Idiopathic pulmonary fibrosis. (2022/12/01) ♡
- Smoking-related interstitial lung disease. (2022/12/01) ♡
- Idiopathic pleuroparenchymal fibroelastosis. (2022/12/01) ♡
- GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. SUCCESSFULLY TREATED ACUTE INTERSTITIAL PNEUMONIA. (2022/12/01) ♡
- Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis. (2022/11/29) ♡
- Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis. (2022/11/29) ♡
- Systematic Analysis Strategy Based on Network Pharmacology to Investigate the Potential Mechanism of Fritillaria thunbergii Miq. against Idiopathic Pulmonary Fibrosis. (2022/11/28) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparison of 4 kinds of traditional Chinese medicine injections to assist in improving clinical indicators of patients with idiopathic pulmonary fibrosis: A systematic review and network meta-analysis. (2022/11/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sexual Dimorphism in Interstitial Lung Disease. (2022/11/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective. (2022/11/23) ♡
- Analysis of the Potential Relationship between Aging and Pulmonary Fibrosis Based on Transcriptome. (2022/11/23) ♡
- Content Analysis of Idiopathic Pulmonary Fibrosis-related Information on Twitter. (2022/11/15) ♡
- The Role of Serum 1,25-Dihydroxy Vitamin D3 and PCT in Idiopathic Pulmonary Fibrosis. (2022/11/08) ♡
- Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis. (2022/11/01) ♡
- SARC-F scores can predict health status and daily activity in patients with idiopathic pulmonary fibrosis. (2022/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Plumbagin attenuates Bleomycin-induced lung fibrosis in mice. (2022/10/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Promising Idiopathic Pulmonary Fibrosis Therapeutics. (2022/10/20) ♡
- Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics. (2022/10/12) ♡
- Analysis of postoperative weight loss associated with prognosis after lobectomy for lung cancer. (2022/10/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation. (2022/10/01) ♡
- Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients. (2022/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The importance of lung biopsy in a patient with idiopathic pulmonary fibrosis: a case report. (2022/10/01) ♡
- Identification and immune characteristics of molecular subtypes related to fatty acid metabolism in idiopathic pulmonary fibrosis. (2022/09/23) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach. (2022/09/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. (2022/09/02) ♡
- Integrated RNA-sequencing and network pharmacology approach reveals the protection of Yiqi Huoxue formula against idiopathic pulmonary fibrosis by interfering with core transcription factors. (2022/09/01) ♡
- National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care. (2022/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Idiopathic pulmonary fibrosis. (2022/08/26) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough? (2022/08/01) ♡
- Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology. (2022/07/20) ♡
- Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study. (2022/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Infectious Exacerbations of Idiopathic Pulmonary Fibrosis. (2022/07/01) ♡
- Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis. (2022/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. (2022/06/29) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.